Novo Nordisk (NVO) has released an update.
On 7 August 2024, Novo Nordisk launched a share repurchase program, committing up to DKK 2.4 billion to buy back shares until November 2024, as part of a larger DKK 20 billion buyback initiative over 12 months initiated in February 2024. As of 13 September, the company has repurchased 12,235,249 B shares at an average price of DKK 881.30 each, totaling nearly DKK 10.8 billion. This repurchase strategy underscores Novo Nordisk’s robust financial position and commitment to shareholder value.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
